172 related articles for article (PubMed ID: 34091189)
41. Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial.
Lübbert M; Grishina O; Schmoor C; Schlenk RF; Jost E; Crysandt M; Heuser M; Thol F; Salih HR; Schittenhelm MM; Germing U; Kuendgen A; Götze KS; Lindemann HW; Müller-Tidow C; Heil G; Scholl S; Bug G; Schwaenen C; Giagounidis A; Neubauer A; Krauter J; Brugger W; De Wit M; Wäsch R; Becker H; May AM; Duyster J; Döhner K; Ganser A; Hackanson B; Döhner H;
J Clin Oncol; 2020 Jan; 38(3):257-270. PubMed ID: 31794324
[TBL] [Abstract][Full Text] [Related]
42. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
[TBL] [Abstract][Full Text] [Related]
43. A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy.
Wass M; Göllner S; Besenbeck B; Schlenk RF; Mundmann P; Göthert JR; Noppeney R; Schliemann C; Mikesch JH; Lenz G; Dugas M; Wermke M; Röllig C; Bornhäuser M; Serve H; Platzbecker U; Foerster KI; Burhenne J; Haefeli WE; Müller LP; Binder M; Pabst C; Müller-Tidow C;
Leukemia; 2021 Mar; 35(3):701-711. PubMed ID: 32561840
[TBL] [Abstract][Full Text] [Related]
44. Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma.
de Sousa LG; Neto FL; Lin J; Ferrarotto R
Curr Oncol Rep; 2022 May; 24(5):621-631. PubMed ID: 35212920
[TBL] [Abstract][Full Text] [Related]
45. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
46. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Estey EH; Thall PF; Pierce S; Cortes J; Beran M; Kantarjian H; Keating MJ; Andreeff M; Freireich E
Blood; 1999 Apr; 93(8):2478-84. PubMed ID: 10194425
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate.
Ha H; Keam B; Ock CY; Heo DS
Chin Clin Oncol; 2020 Apr; 9(2):15. PubMed ID: 32366107
[TBL] [Abstract][Full Text] [Related]
48. All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications.
Defer GL; Adle-Biassette H; Ricolfi F; Martin L; Authier FJ; Chomienne C; Degos L; Degos JD
J Neurooncol; 1997 Sep; 34(2):169-77. PubMed ID: 9210065
[TBL] [Abstract][Full Text] [Related]
49. Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
Feng FE; Feng R; Wang M; Zhang JM; Jiang H; Jiang Q; Lu J; Liu H; Peng J; Hou M; Shen JL; Wang JW; Xu LP; Liu KY; Huang XJ; Zhang XH
Lancet Haematol; 2017 Oct; 4(10):e487-e496. PubMed ID: 28917657
[TBL] [Abstract][Full Text] [Related]
50. Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy.
Thomas X; Anglaret B; Thiebaut A; Belhabri A; Treille-Ritouet D; Fiere D; Archimbaud E
Ann Hematol; 1997; 75(5-6):195-200. PubMed ID: 9433375
[TBL] [Abstract][Full Text] [Related]
51. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
Toma S; Raffo P; Nicolo G; Canavese G; Margallo E; Vecchio C; Dastoli G; Iacona I; Regazzi-Bonora M
Int J Oncol; 2000 Nov; 17(5):991-1000. PubMed ID: 11029503
[TBL] [Abstract][Full Text] [Related]
52. Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial.
Hitre E; Budai B; Takácsi-Nagy Z; Rubovszky G; Tóth E; Remenár É; Polgár C; Láng I
Br J Cancer; 2013 Sep; 109(5):1117-22. PubMed ID: 23942070
[TBL] [Abstract][Full Text] [Related]
53. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
[TBL] [Abstract][Full Text] [Related]
54. Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.
Tobin RP; Cogswell DT; Cates VM; Davis DM; Borgers JSW; Van Gulick RJ; Katsnelson E; Couts KL; Jordan KR; Gao D; Davila E; Medina TM; Lewis KD; Gonzalez R; McFarland RW; Robinson WA; McCarter MD
Clin Cancer Res; 2023 Apr; 29(7):1209-1219. PubMed ID: 36378549
[TBL] [Abstract][Full Text] [Related]
55. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura U; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Tsubaki K; Saito K; Kuriyama K; Oh H; Kitano K; Miyawaki S; Takeyama U; Yamada O; Nishikawa K; Takahashi M; Matsuda S; Ohtake H; Ohno R
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.
Hoover AC; Milhem MM; Anderson CM; Sun W; Smith BJ; Hoffman HT; Buatti JM
Head Neck; 2015 May; 37(5):722-6. PubMed ID: 24596143
[TBL] [Abstract][Full Text] [Related]
57. Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.
Thomson DJ; Silva P; Denton K; Bonington S; Mak SK; Swindell R; Homer J; Sykes AJ; Lee LW; Yap BK; Slevin NJ
Head Neck; 2015 Feb; 37(2):182-7. PubMed ID: 24346857
[TBL] [Abstract][Full Text] [Related]
58. A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.
Kim DW; Oh DY; Shin SH; Kang JH; Cho BC; Chung JS; Kim H; Park KU; Kwon JH; Han JY; Kim MJ; Bang YJ
BMC Cancer; 2014 Nov; 14():795. PubMed ID: 25362970
[TBL] [Abstract][Full Text] [Related]
59. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.
Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R
Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
